Puerto Rico Pharmaceuticals and Healthcare Report Q3 2014

Puerto Rico Pharmaceuticals and Healthcare Report Q3 2014

Includes 3 FREE quarterly updates
BMI View: The pharmaceutical manufacturing industry will continue to be an economic mainstay for Puerto Rico. However, the country is gradually losing attractiveness as a global pharmaceutical production hub, despite the diversification to the generic and biologic drug production.

Headline Expenditure Projections
- Pharmaceuticals: USD3.02bn in 2013 to USD3.02bn in 2014; +0.2% in local currency terms. Forecast is below the previous quarter's projection due to new historical numbers.
- Healthcare: USD7.76bn in 2013 to USD8.02bn in 2014; +3.4% in local currency terms. Forecast below Q214 due to less promising macroeconomic outlook.
BMI Industry View . 7
SWOT .. 8
Industry Forecast 10
Pharmaceutical Market Forecast .. 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Puerto Rico 2010-2018) . . 11
Healthcare Market Forecast ... 12
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Puerto Rico 2010-2018) . . . 14
Prescription Drug Market Forecast ... 14
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2010-2018) . 16
Patented Drug Market Forecast ... 16
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2010-2018) . 18
Generic Drug Market Forecast .... 18
Table: Generics Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2010-2018) . 20
OTC Medicine Market Forecast ... 20
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Puerto Rico 2010-2018) . . . 21
Pharmaceutical Trade Forecast ... 22
Table: Pharmaceutical Trade Data And Forecasts (Puerto Rico 2012-2018) . 25
Other Healthcare Data 25
Key Risks To BMI's Forecast Scenario 25
Macroeconomic Forecasts 27
Puerto Rico 27
Table: Puerto Rico - Gdp By Expenditure, Real Growth % 31
Industry Risk Reward Ratings 32
Americas Risk/Reward Ratings 32
Puerto Rico Risk/Reward Ratings . 38
Rewards ... 38
Risks ... 39
Market Overview . 40
Industry Trends And Developments 41
Epidemiology . 41
Healthcare Sector 42
Effects of US Healthcare Reform . 44
Healthcare Financing 45
Healthcare Provision . 46
Medical Tourism .. 46
Research & Development 47
Biotechnology 48
Clinical Trials 50
Regulatory Development ... 51
Pricing and Reimbursement .. 51
Tax Incentives 52
Table: Incentives, Benefits And Discounts For Pharmaceutical Manufacturers . . . 54
Trade Accords 55
Competitive Landscape 56
Pharmaceutical Industry . 58
Table: Major International Drugmakers In Puerto Rico . . . 58
Pharmaceutical Production ... 61
Plant Expansions . 62
Table: Puerto Rico Continues To Attract Foreign Investment, Despite Challenges . . . 63
Plant Closures 64
Company Developments .. 66
Pharmaceutical Wholesale .... 66
Pharmaceutical Retail 67
Company Profile .. 69
Pfizer ... 69
GlaxoSmithKline ... 71
Merck & Co 73
Abbott Laboratories .... 76
Novartis 79
Sanofi ... 81
Eli Lilly 83
Johnson & Johnson (J&J) . 86
Demographic Forecast . 89
Puerto Rico 89
Table: Puerto Rico's Population By Age Group, 1990-2020 ('000) 90
Table: Puerto Rico's Population By Age Group, 1990-2020 (% of total) . . 91
Table: Puerto Rico's Key Population Ratios, 1990-2020 . . 92
Table: Puerto Rico's Rural And Urban Population, 1990-2020 92
Glossary 93
Methodology ... 95
Pharmaceutical Expenditure Forecast Model .... 95
Healthcare Expenditure Forecast Model . 95
Notes On Methodology .... 96
Risk/Reward Ratings Methodology ... 97
Ratings Overview . 98
Table: Pharmaceutical Risk/Reward Ratings Indicators . . . 98
Indicator Weightings . 99
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.